GLYC
Glycomimetics Inc · HEALTHCARE
Invus Public Equities, L.P. bought $37K of Glycomimetics Inc
10% owner
Bought$37,123
$3.24Price
11,451Shares
What GLYC did for a copier
- $1,000 copied at Mon, Feb 13 close, $378.00
- $370
- S&P 500, same days
- −3.8%
Measured over 30 trading days, to the Mar 28 close.
Invus Public Equities, L.P.'s record
4 other buys with 3 months of prices since 2017: on average −6.1% against the S&P 500, and 2 of 4 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Thu, Feb 9. Filed Mon, Feb 13, 12:45 PM ET, during the session. Returns use the Feb 13 close and the Mar 28 close. Not investment advice.